Form4.ai tracks every SEC insider trade in real time. See every AGIO insider filing with a free account — no card.

See every AGIO insider filing

Free account

AGIOS PHARMACEUTICALS, INC. (AGIO) Insider Trading

AGIOS PHARMACEUTICALS, INC. (AGIO) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $914K. Most recent filing: Oct. 28, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $914K (100%)
  • Sold $914K · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 1 (33%) Grants, exercises & other: 2 (67%)
  • Sales 1 · 33%
  • Grants, exercises & other 2 · 67%

At a glance

Insiders trading
1
Largest buy
—
Most recent filing
Oct 28, 2026

Latest AGIO Form 4 filings

Date Insider Trade Value Price since buy
Oct 28, 2026 SEC filing Gheuens Sarah Chief Medical Officer Cashless exercise $99,741 —
Oct 23, 2026 SEC filing Gheuens Sarah Chief Medical Officer Vest & sell-to-cover 0 sh —
Aug 6, 2026 SEC filing Gheuens Sarah Chief Medical Officer Sold $914,400 —

See every AGIO insider trade

Create a free account to see all 3 AGIO filings from the last 90 days. No card needed.

Create free account

Want AGIO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.